Abstract
In this work, an innovative drug delivery system based on cyclic RGD-modified (as the targeting agent) and doxorubicin-loaded graphene quantum dots (R–GQDs@DOX) was fabricated for chemo-photothermal combination therapy. These tasks include drug loading capacity, photothermal efficiency, cellular uptake and combination therapeutic effect of R–GQDs@DOX. The structure of R–GQDs@DOX was characterized by FT-IR spectrum, UV–vis spectrum and AFM. The results indicated that the doxorubicin (DOX) could be loaded onto graphene quantum dots (GQDs) via van der Waals interaction (π–π stacking) and the drug loading capacity was 96.6 % (wt). The R–GQDs@DOX not only showed obvious pH-responsive release of DOX, but also exhibited great photothermal efficacy for cancer cells. The fluorescence intensity indicated that R–GQDs@DOX was effectively taken up by SK–mel–5 and H460 cells. The combination of chemotherapy and photothermal therapy could more effectively inhibit growth of tumor cells, compared to photothermal therapy or chemotherapy alone.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.